A standardized clinical evaluation of patients affected by facioscapulohumeral muscular dystrophy: The FSHD clinical score
暂无分享,去创建一个
Gabriele Siciliano | Lucio Santoro | Leda Volpi | Roberto D'Amico | Francesca Greco | Enzo Ricci | Rossella Tupler | L. Santoro | C. Angelini | G. Siciliano | E. Ricci | R. Tupler | R. D'amico | C. Lamperti | M. Moggio | L. Volpi | C. Rodolico | C. Fiorillo | Giuliana Galluzzi | Liliana Vercelli | Chiara Fiorillo | Corrado Angelini | Maurizio Moggio | Costanza Lamperti | Greta Fabbri | Roberto Frusciante | Emanuela Bonifazi | Carlo Borsato | Michelangelo Cao | Maura Servida | Rita Di Leo | Claudia Manzoli | Paola Cudia | Ebe Pastorello | Leopoldo Ricciardi | Carmelo Rodolico | Giuliano Tomelleri | Laura Palmucci | R. Frusciante | C. Manzoli | G. Tomelleri | P. Cudia | E. Bonifazi | E. Pastorello | L. Palmucci | G. Galluzzi | R. di Leo | L. Ricciardi | M. Servida | F. Greco | L. Vercelli | C. Borsato | G. Fabbri | Michelangelo Cao
[1] R. Griggs,et al. Randomized, double-blind, placebo-controlled trial of albuterol in facioscapulohumeral dystrophy , 2001, Neurology.
[2] M. Memmi,et al. Identical de novo mutation at the D4F104S1 locus in monozygotic male twins affected by facioscapulohumeral muscular dystrophy (FSHD) with different clinical expression. , 1998, Journal of medical genetics.
[3] M. Brooke,et al. Clinical trial in duchenne dystrophy. I. The design of the protocol , 1981, Muscle & nerve.
[4] M. Passos-Bueno,et al. Asymptomatic carriers and gender differences in facioscapulohumeral muscular dystrophy (FSHD) , 2004, Neuromuscular Disorders.
[5] J. R. Landis,et al. The measurement of observer agreement for categorical data. , 1977, Biometrics.
[6] R. Griggs,et al. Evidence for anticipation and association of deletion size with severity in facioscapulohumerd muscular dystrophy , 1996 .
[7] C. Angelini,et al. Facioscapulohumeral Muscular Dystrophy and Occurrence of Heart Arrhythmia , 2006, European Neurology.
[8] G. Bleijenberg,et al. Effects of training and albuterol on pain and fatigue in facioscapulohumeral muscular dystrophy , 2007, Journal of Neurology.
[9] F. Mangiola,et al. Progress in the molecular diagnosis of facioscapulohumeral muscular dystrophy and correlation between the number of KpnI repeats at the 4q35 locus and clinical phenotype , 1999, Annals of neurology.
[10] B. Everitt,et al. Statistical methods for rates and proportions , 1973 .
[11] O. Brouwer,et al. The influence of handedness on the distribution of muscular weakness of the arm in facioscapulohumeral muscular dystrophy. , 1992, Brain : a journal of neurology.
[12] C. Wijmenga,et al. Genetic linkage map of facioscapulohumeral muscular dystrophy and five polymorphic loci on chromosome 4q35-qter. , 1992, American journal of human genetics.
[13] P. Lunt,et al. 44th ENMC International Workshop: Facioscapulohumeral Muscular Dystrophy: Molecular Studies 19–21 July 1996, Naarden, The Netherlands , 1998, Neuromuscular Disorders.
[14] J E Hewitt,et al. FSHD associated DNA rearrangements are due to deletions of integral copies of a 3.2 kb tandemly repeated unit. , 1993, Human molecular genetics.
[15] P. Harper,et al. Correlation between fragment size at D4F104S1 and age at onset or at wheelchair use, with a possible generational effect, accounts for much phenotypic variation in 4q35-facioscapulohumeral muscular dystrophy (FSHD) , 1995, Human molecular genetics.
[16] S. Pandya,et al. Facioscapulohumeral dystrophy natural history study: standardization of testing procedures and reliability of measurements. The FSH DY Group. , 1994, Physical therapy.
[17] W. Grove. Statistical Methods for Rates and Proportions, 2nd ed , 1981 .